AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.
Based on 303 businesses audited.
Government, Municipal & Public Sector BS: U.S. Food and Drug Administration (www.fda.gov)
The FDA website provides a masterclass in substantive communication, completely devoid of marketing fluff and jargon-heavy sales language. However, the site is technically crippled in this data sample, with a 100% failure rate on critical sub-pages like ‘Contact’ and ‘About.’ It is a fortress of evidence-based information that suffers from a severe accessibility and structured data deficit.
Fix the technical architecture to ensure that the 510K search, safety recalls, and contact pages do not return ‘Not found’ errors. Implement robust Organization and NewsArticle JSON-LD schema to bridge the authority gap and connect ‘FDA Voices’ to verifiable Person profiles. Replace the generic review_count with direct links to the published audit reports and financial statements as per industry proof expectations. Ensure that technical hierarchy is maintained across the currently empty sub-pages to support the transparency claims made on the homepage.
The site exhibits zero heading fluff, with H1 and H4 tags utilizing high-specificity nouns and technical terms like ‘Post-Market Assessment Program,’ ‘BHT, ADA,’ and ‘National Priority Voucher Pilot Program.’ Body text maintains a high substance ratio, citing ‘chemical contaminants in infant formula’ and specific gene therapy treatments for ‘genetic hearing loss.’ There is no evidence of concept repetition; every press announcement and featured topic introduces distinct, measurable regulatory actions. Specificity is maximized through the use of exact dates (May 12, 2026) and specific legal/technical frameworks (483s, EUAs, 510Ks).
AI crawlers don't scroll, click, or wait — they take whatever the raw HTML gives them. Start your free crawl layer inspection and see whether your site is actually reachable in an AI native environment.
A significant semantic disconnect exists between the high-functioning, content-rich homepage and the five sub-pages analyzed, which all returned ‘Not found’ or insufficient data. While the homepage promises a comprehensive regulatory gateway with links to ‘Warning Letters’ and ‘Import Programs,’ the actual user path terminates in technical dead ends for ‘Contact FDA’ and ‘About FDA’ pages. This technical drift suggests a failure to deliver the ‘Information For’ and ‘Regulatory Information’ structures promised in the homepage H2 and H3 hierarchy. The core identity as a transparent public agency is undermined by the inability of 83% of the sampled pages to provide any substantive content.
Our Authority as a Service model transforms raw diagnostic data into high stakes results. Start your Clinical Strategic Diagnosis for 1 Euro to secure the strategic fixes required for growth.
There is no evidence of trust theatre; the site relies on primary regulatory outputs rather than social proof or unverified testimonials. While the page data indicates a review_count of 13, these are not prominently displayed as marketing fluff, and the presence of technical proof links to Guidance Documents provides external validation. The ‘proof_links_count’ of 1 is low for the amount of claims made, but the claims themselves are self-validating regulatory notices.
The ratio of verifiable evidence to assertions is exceptionally high, with every H4 headline serving as a link to a specific outcome or policy change. The site provides high-density proof paths to technical databases (Drug Databases, 510Ks) which function as the ultimate evidence of regulatory activity. There are 8+ instances of specific evidence on the homepage alone, including dates from within 11 days of the temporal anchor.
To review a full competitive diagnostic applied to an enterprise level technical SEO agency, including a direct comparison against Dejan, examine the complete executive audit. View the iPullRank Executive SEO Strategy Dashboard for a practical example of how perception gaps, value prop drift, and audience misalignment are surfaced in real audits.
The value proposition is entirely unique and could not be applied to any other entity, given the FDA’s specific oversight of ‘Tobacco Products,’ ‘Radiation-Emitting Products,’ and ‘Vaccines, Blood, and Biologics.’ There is a total absence of generic marketing clichés or value-prop cliches like ‘government that works for you.’ Template fingerprints like ‘Featured Topics’ are populated with high-utility technical shortcuts (483s, EUAs) rather than generic ‘About Us’ boilerplate. The positioning is clearly differentiated through specific regulatory protocols that are non-commoditized.
A critical technical credibility gap exists as 5 out of 6 pages are ‘Not found,’ failing the requirement for a clean technical implementation. The schema_json is null across the board, which is a major authority gap for a primary government entity that should be utilizing Organization and NewsArticle structured data. While ‘FDA Voices’ is referenced, the lack of Person schema or sameAs links for experts in the provided data prevents full verification of individual digital footprints.
The site avoids vague performance claims in favor of specific regulatory results, such as the ‘Seventh Approval’ under the National Priority Voucher Pilot Program. The marketing tone is strictly objective and news-based, with no ‘proven track record’ fluff without accompanying data. Every claim, such as the ‘Largest-Ever Testing of Infant Formula,’ is supported by specific context regarding the ‘rigorous examination’ and its focus on ‘chemical contaminants.’
Government, Municipal & Public Sector BS: U.S. Food and Drug Administration (www.fda.gov)
The content perfectly aligns with the Government and Public Sector classification through its focus on regulatory frameworks and public health mandates. Technical identifiers such as 483s, 510Ks, and EUAs confirm its role as a specific regulatory authority rather than a generic service provider.
If your entity graph is unstable, every other part of the framework inherits that instability. Study the Structured Data Framework Guide and see why schema is not markup — it is the machine readable definition of your domain.
“The BS score of 18 is driven entirely by technical failure and identity gaps rather than content fluff. The Semantic Coherence pillar (8/20) and Identity and Authority pillar (10/15) penalize the 83% failure rate of the sub-pages and the absence of structured data. The content itself scored 0 for BS in Information Density, Trust, and Commodity categories, reflecting its extreme substance.”
Analysis Disclosure & Source Attribution
Snapshot Date: May 19, 2026
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to see how machine logic interprets digital signals.
Machine Perception Notice: This evaluation is generated by machine-read logic (MRL). The AI interprets the “Digital Ghost” of a website (code, metadata, and semantic structures), which may differ from what a human sees at the same moment. This is an automated technical diagnostic and not a statement of fact or human opinion regarding the real-world integrity or legitimacy of the business. Any missing or inaccessible elements in the snapshot are treated as machine-read signals, reflecting AI rendering limitations rather than intentional omission.
Notice to the Evaluated Business: This analysis is part of a non-adversarial audit. The results are intended as professional feedback to help improve machine-readability and authority signals. Any company can use these insights for free. When content is updated, a fresh audit can be requested at any time to reflect the current state.
To All Users: You are encouraged to visit the live site at U.S. Food and Drug Administration to view the most current version of their content and see directly what the company offers.